Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-14 · accession 0001855763-24-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-15 | 2024-05-14 | LEXX | Carle Vanessa | Sec | M - OptEx | $1.15 | +2,500 | 2,567 | +3,731% | +$2,875 |
| D | 2024-05-15 | 2024-05-14 | LEXX | Carle Vanessa | Sec | M - OptEx | $0.00 | -2,500 | 60.1K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2024-05-14 | M | A | 2,500 | $1.15 | 2,567 | D | — | — | |
| 2 | Derivative | Stock Options | 2024-05-14 | M | D | 2,500 | $0.00 | 60,067 | D | $1.15 · 2023-10-26 to 2028-10-26 | 2,500 Common Shares |